Imago BioSciences, Inc. Operating Lease, Expense
Imago BioSciences, Inc. reported Operating Lease, Expense of $24.00 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2022-11-09
- Imago BioSciences, Inc. operating lease, expense for the quarter ending 2022-09-30 was $24.00M, a 14.29% increase year-over-year.
- Imago BioSciences, Inc. operating lease, expense for the quarter ending 2022-06-30 was $18.00M, a 10.00% decline year-over-year.
- Imago BioSciences, Inc. operating lease, expense for the quarter ending 2022-03-31 was $22.00M, a 26.67% decline year-over-year.
- Imago BioSciences, Inc. operating lease, expense for the quarter ending 2021-12-31 was -$70.90M, a 295516.67% decline year-over-year.
- Imago BioSciences, Inc. operating lease, expense for fiscal 2021 was $100.00K, a 0.00% change from fiscal 2020.
- Imago BioSciences, Inc. operating lease, expense for fiscal 2020 was $100.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 3 month as first filed | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 9 month as first filed | Operating Lease, Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2022-09-30 | $24.00M 10-Q · filed 2022-11-09 | $42.00M derived: sum of 2 quarters · filed 2022-11-09 | $64.00M 10-Q · filed 2022-11-09 | -$6.90M derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2022-06-30 | $18.00M 10-Q · filed 2022-08-12 | $40.00M 10-Q · filed 2022-08-12 | -$30.90M derived: sum of 3 quarters · filed 2022-08-12 | -$9.90M derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2022-03-31 | $22.00M 10-Q · filed 2022-05-12 | -$48.90M derived: sum of 2 quarters · filed 2022-05-12 | -$27.90M derived: sum of 3 quarters · filed 2022-11-09 | -$7.90M derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-12-31 | -$70.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$49.90M derived: sum of 2 quarters · filed 2022-11-09 | -$29.90M derived: sum of 3 quarters · filed 2022-11-09 | $100.00K 10-K · filed 2022-03-24 | |||
| 2021-09-30 | $21.00M 10-Q · filed 2022-11-09 | $21.00K 10-Q · filed 2021-11-10 | $41.00M derived: sum of 2 quarters · filed 2022-11-09 | $71.00M 10-Q · filed 2022-11-09 | $71.00K 10-Q · filed 2021-11-10 | $71.02M derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | $20.00M 10-Q · filed 2022-08-12 | $20.00K 10-Q · filed 2021-08-19 | $50.00M 10-Q · filed 2022-08-12 | $50.00K 10-Q · filed 2021-08-19 | $50.02M derived: sum of 3 quarters · filed 2022-08-12 | $50.05M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $30.00M 10-Q · filed 2022-05-12 | $30.02M derived: sum of 2 quarters · filed 2022-05-12 | $30.05M derived: sum of 3 quarters · filed 2022-05-12 | $30.07M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $52.00K derived: sum of 2 quarters · filed 2022-03-24 | $73.00K derived: sum of 3 quarters · filed 2022-03-24 | $100.00K 10-K · filed 2022-03-24 | |||
| 2020-09-30 | $28.00K 10-Q · filed 2021-11-10 | $49.00K derived: sum of 2 quarters · filed 2021-11-10 | $76.00K 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | $21.00K 10-Q · filed 2021-08-19 | $48.00K 10-Q · filed 2021-08-19 |